These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11385443)

  • 21. Ontario--hot biotechnology in a cold climate.
    McIntyre H
    Nat Biotechnol; 2001 Jun; 19(6):523-5. PubMed ID: 11385446
    [No Abstract]   [Full Text] [Related]  

  • 22. Biotechnology in the Bay.
    Niiler E
    Nat Biotechnol; 2000 Mar; 18(3):280-1. PubMed ID: 10700141
    [No Abstract]   [Full Text] [Related]  

  • 23. Putting a price on biotechnology.
    Stewart JJ; Allison PN; Johnson RS
    Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634
    [No Abstract]   [Full Text] [Related]  

  • 24. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 25. Realities for Latin American and Caribbean biotech.
    Rangel-Aldao R
    Nat Biotechnol; 2004 Jan; 22(1):20. PubMed ID: 14704694
    [No Abstract]   [Full Text] [Related]  

  • 26. The 20-year African biotech plan.
    Singh JA; Daar AS
    Nat Biotechnol; 2008 Mar; 26(3):272-4. PubMed ID: 18327231
    [No Abstract]   [Full Text] [Related]  

  • 27. Biotechnology and bioeconomy in China.
    Li Q; Zhao Q; Hu Y; Wang H
    Biotechnol J; 2006 Nov; 1(11):1205-14. PubMed ID: 17109491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vapornomics.
    Paris M
    Nat Biotechnol; 2001 Apr; 19(4):301. PubMed ID: 11283574
    [No Abstract]   [Full Text] [Related]  

  • 29. Dreams and reality.
    Nat Biotechnol; 2001 Dec; 19(12):1087. PubMed ID: 11731760
    [No Abstract]   [Full Text] [Related]  

  • 30. Sumitomo buys Oxford finance.
    Bouchie A
    Nat Biotechnol; 2004 Apr; 22(4):480. PubMed ID: 15085808
    [No Abstract]   [Full Text] [Related]  

  • 31. A blueprint for biotech's blues.
    Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 33. Boosting biotech in Finland.
    Smaglik P
    Nature; 2004 Oct; 431(7011):1020-1. PubMed ID: 15496931
    [No Abstract]   [Full Text] [Related]  

  • 34. Building Nordic networks.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A3, A5, A7. PubMed ID: 12501120
    [No Abstract]   [Full Text] [Related]  

  • 35. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 36. Finnish biotechnology--built on solid foundations.
    Lähteenmäki R
    Nat Biotechnol; 2002 May; 20(5):437-40. PubMed ID: 11981550
    [No Abstract]   [Full Text] [Related]  

  • 37. Fickle financing climate continues.
    Mitchell P
    Nat Biotechnol; 2001 Aug; 19(8):695-6. PubMed ID: 11479542
    [No Abstract]   [Full Text] [Related]  

  • 38. The number on biotech indexes.
    Jacobs T
    Nat Biotechnol; 2005 Nov; 23(11):1356. PubMed ID: 16273059
    [No Abstract]   [Full Text] [Related]  

  • 39. India shuts door on embryonic export market.
    Jayaraman KS
    Nature; 2002 Sep; 419(6904):238. PubMed ID: 12239528
    [No Abstract]   [Full Text] [Related]  

  • 40. China's efforts to lure biotechs to bio-island criticized.
    Niiler E
    Nat Biotechnol; 2000 Jul; 18(7):708. PubMed ID: 10888828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.